Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More [Yahoo! Finance]
Crinetics Pharmaceuticals, Inc. (CRNX)
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
the sale of 5,000 shares of common stock in open-market transactions on March 12, 2026, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$181K Post-transaction common shares (direct) Post-transaction value (direct ownership) ~$595K Transaction value based on SEC Form 4 weighted average purchase price ($36.15). Key questions How does the size of this sale compare to Coelho's past trade history? This is the only open-market sale disclosed by Coelho for Crinetics Pharmaceuticals. What was the proportion of direct ownership affected by this transaction? The sale accounted for 23.47% of Coelho's direct common stock holdings, reducing the position from 21,300 to 16,300 shares, with all remaining shares held directly and no indirect or derivative exposure reported in the Form 4. Was this transaction part of a routine liquidity plan? Yes, the filing specifies the sale was executed automatically under a
Show less
Read more
Impact Snapshot
Event Time:
CRNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRNX alerts
High impacting Crinetics Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CRNX
News
- Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in AcromegalyGlobeNewswire
- Crinetics Pharma COO to step down [Seeking Alpha]Seeking Alpha
- Is Crinetics Pharmaceuticals (CRNX) Pricing Reflect Its Sharp Swings And DCF Upside Potential [Yahoo! Finance]Yahoo! Finance
- Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf. [Yahoo! Finance]Yahoo! Finance
- Crinetics Pharmaceuticals (CRNX) had its price target lowered by Citizens Jmp from $105.00 to $96.00. They now have a "market outperform" rating on the stock.MarketBeat
CRNX
Earnings
- 2/26/26 - Beat
CRNX
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/23/26 - Form 8-K
- 3/18/26 - Form 4
- CRNX's page on the SEC website